A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo
出版年份 2022 全文链接
标题
A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo
作者
关键词
-
出版物
BIOCHEMICAL PHARMACOLOGY
Volume 201, Issue -, Pages 115070
出版商
Elsevier BV
发表日期
2022-05-06
DOI
10.1016/j.bcp.2022.115070
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Progress of tubulin polymerization activity detection methods
- (2021) Ting Zhu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Novel diaryl-2H-azirines: Antitumor hybrids for dual-targeting tubulin and DNA
- (2021) Shibo Lin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis, and biological evaluation of novel dual inhibitors targeting lysine specific demethylase 1 (LSD1) and histone deacetylases (HDAC) for treatment of gastric cancer
- (2021) Ying-Chao Duan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Cancer epigenetics: Past, present and future
- (2021) Jae Eun Lee et al. SEMINARS IN CANCER BIOLOGY
- Efficient Synthesis and Bioevaluation of Novel Dual Tubulin/Histone Deacetylase 3 Inhibitors as Potential Anticancer Agents
- (2021) Xiaopeng Peng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy
- (2021) Wen Shuai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel Diarylamide N-Containing Heterocyclic Derivatives as New Tubulin Polymerization Inhibitors with Anti-Cancer Activity
- (2021) Xu Liu et al. MOLECULES
- Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities
- (2021) Ya-Xin Sun et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Research progress of dual inhibitors targeting crosstalk between histone epigenetic modulators for cancer therapy
- (2021) Ying-Chao Duan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting cancer epigenetic pathways with small-molecule compounds: Therapeutic efficacy and combination therapies
- (2021) Yi Wang et al. PHARMACOLOGICAL RESEARCH
- Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles
- (2021) Linda Wordeman et al. Cancers
- Role of HDACs in normal and malignant hematopoiesis
- (2020) Pan Wang et al. Molecular Cancer
- Dual-Target Inhibitors Based on HDACs: Novel Antitumor Agents for Cancer Therapy
- (2020) Tingting Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
- (2020) Terence C. S. Ho et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of tertiary amide derivatives incorporating benzothiazole moiety as anti-gastric cancer agents in vitro via inhibiting tubulin polymerization and activating the Hippo signaling pathway
- (2020) Jian Song et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Current status in the discovery of dual BET/HDAC inhibitors
- (2020) Qinghua Ren et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment
- (2020) Xiaopeng Peng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Molecular diversity of trimethoxyphenyl-1,2,3-triazole hybrids as novel colchicine site tubulin polymerization inhibitors
- (2019) Dong-Jun Fu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Epigenetic therapy for ovarian cancer: promise and progress
- (2019) Sara Moufarrij et al. Clinical Epigenetics
- Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy
- (2019) Kinsie E Arnst et al. MEDICINAL RESEARCH REVIEWS
- Targeting epigenetics for cancer therapy
- (2019) Jong Woo Park et al. ARCHIVES OF PHARMACAL RESEARCH
- Recent Study of Dual HDAC/PARP Inhibitor for the Treatment of Tumor
- (2019) Haiying Lu et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Microtubule inhibitors containing immunostimulatory agents promote cancer immunochemotherapy by inhibiting tubulin polymerization and tryptophan-2,3-dioxygenase
- (2019) Shixian Hua et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and anticancer evaluation of acridine hydroxamic acid derivatives as dual Topo and HDAC inhibitors
- (2018) Jiwei Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Dual or multi-targeting inhibitors: The next generation anticancer agents
- (2018) Nulgumnalli Manjunathaiah Raghavendra et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Chimeric HDAC inhibitors: Comprehensive review on the HDAC-based strategies developed to combat cancer
- (2018) Heba M. Hesham et al. MEDICINAL RESEARCH REVIEWS
- Combination Therapies Targeting HDAC and IKK in Solid Tumors
- (2018) Ivana Vancurova et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Bioactive heterocycles containing a 3,4,5-trimethoxyphenyl fragment exerting potent antiproliferative activity through microtubule destabilization
- (2018) Dong-Jun Fu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Deconvolution of Buparlisib’s mechanism of action defines specific PI3K and tubulin inhibitors for therapeutic intervention
- (2017) Thomas Bohnacker et al. Nature Communications
- Epigenetic linkage of aging, cancer and nutrition
- (2015) M. Daniel et al. JOURNAL OF EXPERIMENTAL BIOLOGY
- The synergic effect of vincristine and vorinostat in leukemia in vitro and in vivo
- (2015) Min-Wu Chao et al. Journal of Hematology & Oncology
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- β-Lactam Estrogen Receptor Antagonists and a Dual-Targeting Estrogen Receptor/Tubulin Ligand
- (2014) Niamh M. O’Boyle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
- (2014) Katrina J. Falkenberg et al. NATURE REVIEWS DRUG DISCOVERY
- Discovery of Antitubulin Agents with Antiangiogenic Activity as Single Entities with Multitarget Chemotherapy Potential
- (2014) Aleem Gangjee et al. ACS Medicinal Chemistry Letters
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Basic concepts of epigenetics
- (2012) Elizabeth A. Mazzio et al. Epigenetics
- Histone Deacetylase Inhibitors: Emerging Mechanisms of Resistance
- (2011) Robert W. Robey et al. MOLECULAR PHARMACEUTICS
- Discovery of 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDC-101) as a Potent Multi-Acting HDAC, EGFR, and HER2 Inhibitor for the Treatment of Cancer
- (2010) Xiong Cai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance
- (2009) E. A. Perez MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now